Advancing Therapy in Suboptimally Controlled Basal Insulin-Treated Type 2 Diabetes: Clinical Outcomes With iGlarLixi Versus Premix BIAsp 30 in the SoliMix Randomized Controlled Trial
改善基础胰岛素治疗效果欠佳的 2 型糖尿病患者的治疗：SoliMix 随机对照试验中 iGlarLixi 与预混胰岛素 BIAsp 30 的临床结果
期刊:
影响因子:
doi:10.2337/dc21-0393
Rosenstock, Julio; Emral, Rifat; Sauque-Reyna, Leobardo; Mohan, Viswanathan; Trescolí, Carlos; Al Sifri, Saud; Lalic, Nebojsa; Alvarez, Agustina; Picard, Pascaline; Bonnemaire, Mireille; Demil, Nacima; McCrimmon, Rory J
